Scientific Program
Takeda’s Industry Symposium Webcasts
Debate 1: Use of continuous vs. fixed-duration therapy as treatment approaches in multiple myeloma
Debate 2: Use of triplet vs. doublet combination regimens for the treatment of relapsed/refractory multiple myeloma

+972 3 555 0188

CME Congresses Ltd.

+972 3 540 1566

© COMy Multiple Myeloma Highlights 2017, a post-IMW summary congress